Clinica's New Stock Tracker - featured stock: Genoptix
This article was originally published in Clinica
Executive Summary
Stock Highlight: Genoptix (GXDX) +105% The current turbulent global financial markets have sent medtech shares yo-yoing during the first few months of 2008. Financial uncertainty has resulted in the postponement of many IPOs, including that of French ophthalmic equipment specialist Luneau Technology, which cancelled its IPO on the Euronext's Alternext market on January 29.